CMS Laser Advances Pharmaceutical Production with Innovative Tablet Drilling Technology

Reuters
15 May
CMS Laser Advances Pharmaceutical Production with Innovative Tablet Drilling Technology

Laser Photonics Corporation's subsidiary, Control Micro Systems, Inc. (CMS Laser), is enhancing its position in the pharmaceutical industry with advanced tablet laser drilling technology. This innovation offers precise laser drilling for controlled drug release, improved patient outcomes, anti-counterfeit protection through unique tablet markings, and operational efficiency in production. CMS Laser's systems, designed and manufactured in Winter Park, Florida, cater to a wide range of pharmaceutical needs, including high-volume tablet drilling, marking, and research and development. With a strong market position and a legacy of serving industry giants, CMS Laser continues to provide superior technologies that address industry-specific challenges and support high-volume pill production.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Laser Photonics Corporation published the original content used to generate this news brief via Business Wire (Ref. ID: 20250514938775) on May 14, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10